| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |